Raj Khankari, Ph.D., MBA
CEO OF Ribocor, Inc.
Prior to RiboCor, Dr. Khankari was the General Manager and Vice-President of Worldwide Drug Technologies for CIMA LABS INC., a Cephalon company, where he was responsible for the performance and growth of the drug delivery business for Cephalon. The holder of 15 patents and author of several peer-reviewed journal articles,
Dr. Khankari has more than 16 years of experience in developing and successfully introducing pharmaceutical products to the market. That experience includes numerous technology licensing transactions, domestic and international. While at RiboCor, Dr. Khankari successfully licensed the Corvalen product and divested the bulk ingredient Ribose business. Dr. Khankari holds Ph.D. (Pharmaceutics) and MBA degrees from the University of Minnesota, an MS degree (Physical Pharmacy) from the University of Cincinnati, and an M.Pharm and a B.Pharm from India.